ANIP
Price
$55.10
Change
-$0.00 (-0.00%)
Updated
Oct 10 closing price
26 days until earnings call
COLL
Price
$36.64
Change
-$0.00 (-0.00%)
Updated
Oct 10 closing price
26 days until earnings call
Ad is loading...

ANIP vs COLL

Header iconANIP vs COLL Comparison
Open Charts ANIP vs COLLBanner chart's image
ANI Pharmaceuticals
Price$55.10
Change-$0.00 (-0.00%)
Volume$132.63K
CapitalizationN/A
Collegium Pharmaceutical
Price$36.64
Change-$0.00 (-0.00%)
Volume$501.99K
CapitalizationN/A
View a ticker or compare two or three
ANIP vs COLL Comparison Chart
Loading...
ANIP
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
COLL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
ANIP vs. COLL commentary
Oct 12, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANIP is a StrongBuy and COLL is a StrongBuy.

COMPARISON
Comparison
Oct 12, 2024
Stock price -- (ANIP: $55.10 vs. COLL: $36.64)
Brand notoriety: ANIP and COLL are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ANIP: 32% vs. COLL: 130%
Market capitalization -- ANIP: $1.43B vs. COLL: $1.24B
ANIP [@Pharmaceuticals: Other] is valued at $1.43B. COLL’s [@Pharmaceuticals: Other] market capitalization is $1.24B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANIP’s FA Score shows that 0 FA rating(s) are green whileCOLL’s FA Score has 2 green FA rating(s).

  • ANIP’s FA Score: 0 green, 5 red.
  • COLL’s FA Score: 2 green, 3 red.
According to our system of comparison, COLL is a better buy in the long-term than ANIP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANIP’s TA Score shows that 4 TA indicator(s) are bullish while COLL’s TA Score has 3 bullish TA indicator(s).

  • ANIP’s TA Score: 4 bullish, 6 bearish.
  • COLL’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, ANIP is a better buy in the short-term than COLL.

Price Growth

ANIP (@Pharmaceuticals: Other) experienced а -2.98% price change this week, while COLL (@Pharmaceuticals: Other) price change was -8.15% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +8.21%. For the same industry, the average monthly price growth was +10.22%, and the average quarterly price growth was -2.43%.

Reported Earning Dates

ANIP is expected to report earnings on Feb 27, 2025.

COLL is expected to report earnings on Feb 20, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+8.21% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ANIP($1.43B) has a higher market cap than COLL($1.24B). ANIP has higher P/E ratio than COLL: ANIP (79.85) vs COLL (30.17). COLL YTD gains are higher at: 19.038 vs. ANIP (-0.073). COLL has higher annual earnings (EBITDA): 308M vs. ANIP (107M). COLL has more cash in the bank: 311M vs. ANIP (221M). ANIP has less debt than COLL: ANIP (286M) vs COLL (674M). COLL has higher revenues than ANIP: COLL (567M) vs ANIP (487M).
ANIPCOLLANIP / COLL
Capitalization1.43B1.24B115%
EBITDA107M308M35%
Gain YTD-0.07319.038-0%
P/E Ratio79.8530.17265%
Revenue487M567M86%
Total Cash221M311M71%
Total Debt286M674M42%
FUNDAMENTALS RATINGS
ANIP vs COLL: Fundamental Ratings
ANIP
COLL
OUTLOOK RATING
1..100
6478
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
65
Fair valued
PROFIT vs RISK RATING
1..100
10012
SMR RATING
1..100
8221
PRICE GROWTH RATING
1..100
7544
P/E GROWTH RATING
1..100
94100
SEASONALITY SCORE
1..100
5025

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

COLL's Valuation (65) in the Pharmaceuticals Other industry is in the same range as ANIP (96). This means that COLL’s stock grew similarly to ANIP’s over the last 12 months.

COLL's Profit vs Risk Rating (12) in the Pharmaceuticals Other industry is significantly better than the same rating for ANIP (100). This means that COLL’s stock grew significantly faster than ANIP’s over the last 12 months.

COLL's SMR Rating (21) in the Pharmaceuticals Other industry is somewhat better than the same rating for ANIP (82). This means that COLL’s stock grew somewhat faster than ANIP’s over the last 12 months.

COLL's Price Growth Rating (44) in the Pharmaceuticals Other industry is in the same range as ANIP (75). This means that COLL’s stock grew similarly to ANIP’s over the last 12 months.

ANIP's P/E Growth Rating (94) in the Pharmaceuticals Other industry is in the same range as COLL (100). This means that ANIP’s stock grew similarly to COLL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ANIPCOLL
RSI
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
71%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
72%
MACD
ODDS (%)
Bearish Trend 2 days ago
72%
Bearish Trend 2 days ago
70%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
72%
Bearish Trend 2 days ago
65%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
73%
Bullish Trend 2 days ago
76%
Advances
ODDS (%)
Bullish Trend 12 days ago
72%
Bullish Trend 8 days ago
76%
Declines
ODDS (%)
Bearish Trend 2 days ago
71%
Bearish Trend 2 days ago
64%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
81%
Bearish Trend 2 days ago
63%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
80%
View a ticker or compare two or three
Ad is loading...
ANIP
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
COLL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME20.910.41
+2.00%
GameStop Corp
SPY576.13-1.01
-0.18%
SPDR® S&P 500® ETF Trust
AAPL229.04-0.50
-0.22%
Apple
BTC.X60274.500000-307.601560
-0.51%
Bitcoin cryptocurrency
TSLA238.77-2.28
-0.95%
Tesla

ANIP and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANIP has been loosely correlated with DRRX. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if ANIP jumps, then DRRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANIP
1D Price
Change %
ANIP100%
-2.87%
DRRX - ANIP
39%
Loosely correlated
-1.91%
SNDL - ANIP
31%
Poorly correlated
-1.54%
ORGO - ANIP
30%
Poorly correlated
-3.97%
PETQ - ANIP
29%
Poorly correlated
+0.10%
PRPH - ANIP
29%
Poorly correlated
-2.62%
More